Beam Therapeutics Inc
(NAS:BEAM)
$
36.88
-1.06 (-2.79%)
Market Cap: 3.79 Bil
Enterprise Value: 2.83 Bil
PE Ratio: 0
PB Ratio: 3.26
GF Score: 69/100 Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Oct 27, 2021 / 08:00PM GMT
Release Date Price:
$91.79
(-2.87%)
Michael Yee
(Trades, Portfolio) LLC - Analyst
All right. Well, good afternoon and thank you for joining us on another great session here at the Jefferies virtual Gene Therapy and Gene Editing Summit. We've had a great day so far. A lot of great firesides as well with some folks who are quite familiar with our guest here on this session, Beam Therapeutics. And I was just talking with John about how David Liu had some very nice comments earlier today about where the space is going.
I wanted to, of course, introduce the CEO of Beam Therapeutics, John Evans, here with us. He has been making some great progress along single base pair gene editing, which is a next-generation technology.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot